Results 181 to 190 of about 62,929 (228)

TACE Combined with Ralox-HAIC (Oxaliplatin Puls Raltitrexed) and System Therapy in Patients with Unresectable Hepatocellular Carcinoma. [PDF]

J Hepatocell Carcinoma
Liu R, Cao G, Li L, Liu J, Cao H, Xing M, Feng Y, Li Z, Wang B.   +8 more
europepmc   +1 more source

Late Pulmonary and Lymph Node Recurrence 14 Years after Curative Resection of Incidentally Diagnosed Appendiceal Adenocarcinoma with Hepatic Metastasis. [PDF]

Surg Case Rep
Nishina K, Yamaguchi T, Furukawa M, Kitani Y, Nakane K, Koseki T, Kawasaki K, Takahashi M, Inada K.   +8 more
europepmc   +1 more source

Combined intervention of <i>Akkermansia muciniphila</i> and sodium butyrate ameliorates oxaliplatin-induced peripheral neuropathy by suppressing neuroinflammation and reducing serum neurofilament light chain. [PDF]

Front Immunol
Xu D, Fu D, Chen J, Hu Q, Wang Y, Wu J.
europepmc   +1 more source

Oxaliplatin-induced cardiotoxicity in mice is connected to the changes in energy metabolism in the heart tissue. [PDF]

Cardiooncology
Du J, Sudlow LC, Shahverdi K, Zhou H, Michie MS, Schindler TH, Mitchell JD, Mollah S, Berezin MY.   +8 more
europepmc   +1 more source

Lineage-Specific Disruption of Hematopoiesis by Oxaliplatin: Mechanisms of Erythropoietin Resistance and Immune Suppression. [PDF]

J Hematol Oncol Res
Sudlow LC, Du J, Shahverdi K, Zhou H, Berezin MY.   +4 more
europepmc   +1 more source

DRG Explant Model for Understanding Mechanism of Oxaliplatin-Induced Peripheral Neuropathy and Identifying Potential Therapeutic Targets. [PDF]

Antioxidants (Basel)
Du J, Sudlow LC, Luzhansky ID, Berezin MY.   +3 more
europepmc   +1 more source

Chemotherapy-derived DAMPs drive reprogramming of tumor-associated macrophages toward a pro-inflammatory phenotype in hepatocellular carcinoma. [PDF]

Sci Rep
Songjang W, Paiyabhroma N, Srisuwan C, Promchai S, Nensat C, Pankhong P, Kumphune S, Jiraviriyakul A.   +7 more
europepmc   +1 more source

Impact of <i>UGT1A1*28</i> polymorphism in patients with metastatic pancreatic ductal adenocarcinoma treated with NALIRIFOX in the NAPOLI 3 trial. [PDF]

Future Oncol
Abdelrahim M, Khan G, Hatoum H, Zervoudakis A, Dayyani F, Zhang L, Li J, Maxwell F, O'Reilly EM, Wainberg ZA, Bullock A.   +10 more
europepmc   +1 more source

Retraction: Real-World Outcomes of Peri-Operative Chemotherapy With Fluorouracil, Leucovorin, Oxaliplatin, and Docetaxel in Upper Gastrointestinal Cancers: An Audit of Patients Diagnosed Between 2017 and 2020 at the Christie Hospital. [PDF]

Cureus
Sabry M, Mahmoud Y, Hatahet Y, Patel R, Ibrahim N.   +4 more
europepmc   +1 more source